“crohns disease”的搜索结果，显示 901-910 项，共有 9438 项

1. 外科 - 临床试验- 妙佑医疗国际

   -improve surgical care and quality of life of patients with hip problems/diseases -ID predictors of surgical outcomes to identify/improve future treatments

2. 神经科- 临床试验- 妙佑医疗国际

   ... and (12) up to 6 donors with colorectal cancer who have no clinical evidence of residual (macroscopic) disease following an attempt to perform definitive ...

3. 血液科- 临床试验- 妙佑医疗国际

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Gynecologic Extramammary Paget's Disease. Rochester, Minn. In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... and collect additional blood samples to evaluate for minimal residual disease and tissue at the time of any breast cancer recurrence. KTX-100 MMSET ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small ...

7. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, and ...

8. 妙佑医疗国际移植中心- 临床试验

   ... disease. APOLLO will test DNA from kidney donors and recipients of kidney transplants for APOL1 to determine effects on kidney transplant-related outcomes.

9. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is evaluate the safety of allogeneic adipose derived mesenchymal stem cell (AMSC) use during hemodialysis arteriovenous fistula and ...

10. 肺科- 临床试验- 妙佑医疗国际

    This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setting on cancer care and quality of ...